GABPB1
Basic information
Region (hg38): 15:50275389-50355408
Previous symbols: [ "GABPB2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GABPB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 2 | 1 | 0 |
Variants in GABPB1
This is a list of pathogenic ClinVar variants found in the GABPB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-50286107-G-C | not specified | Uncertain significance (May 18, 2022) | ||
15-50300891-C-T | not specified | Uncertain significance (Apr 27, 2023) | ||
15-50301220-C-A | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GABPB1 | protein_coding | protein_coding | ENST00000220429 | 8 | 78217 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.911 | 0.0888 | 124199 | 4 | 969 | 125172 | 0.00389 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.93 | 90 | 209 | 0.430 | 0.0000101 | 2545 |
Missense in Polyphen | 17 | 70.52 | 0.24107 | 898 | ||
Synonymous | 1.38 | 57 | 71.9 | 0.793 | 0.00000342 | 809 |
Loss of Function | 3.64 | 3 | 21.0 | 0.143 | 0.00000130 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00481 | 0.00481 |
Ashkenazi Jewish | 0.0116 | 0.0116 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000278 | 0.000278 |
European (Non-Finnish) | 0.00423 | 0.00422 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00707 | 0.00706 |
Other | 0.00475 | 0.00476 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor capable of interacting with purine rich repeats (GA repeats). Necessary for the expression of the Adenovirus E4 gene. {ECO:0000269|PubMed:10675337, ECO:0000269|PubMed:8816484}.;
- Pathway
- Myometrial Relaxation and Contraction Pathways;Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex;Mitochondrial Gene Expression;Transcriptional activation of mitochondrial biogenesis;Mitochondrial biogenesis;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- 0.507
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 73.97
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.543
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.955
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gabpb1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;mitochondrion organization;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;cytoplasmic ribonucleoprotein granule
- Molecular function
- DNA-binding transcription factor activity;protein binding;transcription regulatory region DNA binding;protein heterodimerization activity